drontaste
vetoquinol sa - febantel / pyrantelembonat / prazikvantel - tablett - 150 mg / 144 mg / 50 mg
epirubicin accord 2 mg/ ml
accord healthcare b.v. - epirubicinhydroklorid - injeksjons-/infusjonsvæske, oppløsning - 2 mg/ ml
migard 2.5 mg
menarini international o.l. s.a. - frovatriptan - tablett, filmdrasjert - 2.5 mg
nuvaring 0.12 mg/24 timer / 0.015 mg/24 timer
n.v. organon - kloosterstraat - etonogestrel / etinyløstradiol - vaginalinnlegg - 0.12 mg/24 timer / 0.015 mg/24 timer
nematel vet 439 mg/ g
le vet beheer b.v. - pyrantelembonat - oralpasta - 439 mg/ g
otimectin vet 1 mg/ g
le vet b.v. - ivermektin - Øregel - 1 mg/ g
welpan vet 15 mg/ ml / 5 mg/ ml
vetoquinol sa - febantel / pyrantelembonat - mikstur, suspensjon - 15 mg/ ml / 5 mg/ ml
zonnic 2 mg
niconovum ab - nikotin - munnpulver i porsjonspose med mintsmak - 2 mg
zonnic 4 mg
niconovum ab - nikotin - munnpulver i porsjonspose med mintsmak - 4 mg
braftovi
pierre fabre medicament - encorafenib - melanoma; colorectal neoplasms - antineoplastiske midler - encorafenib is indicated:in combination with binimetinib is indicated for the treatment of adult patients with unresectable or metastatic melanoma with a braf v600 mutationin combination with cetuximab, for the treatment of adult patients with metastatic colorectal cancer (crc) with a braf v600e mutation, who have received prior systemic therapy.